Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants

Abstract

ABSTRACTBackgroundViral recombination that occurs by exchanging genetic materials between two viral genomes coinfecting the same host cells is associated with the emergence of new viruses with different virulence. Herein, we detected a patient coinfected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Delta and Omicron variants and identified various recombinants in the SARS‐CoV‐2 full‐length spike gene using long‐read and Sanger sequencing.MethodsSamples from five patients in Japan with household transmission of coronavirus disease 2019 (COVID‐19) were analyzed using molecular assays for detection and identification of SARS‐CoV‐2. Whole‐genome sequencing was conducted using multiplex PCR with short‐read sequencing.ResultsAmong the five SARS‐CoV‐2‐positive patients, the mutation‐specific assay identified the Delta variant in three, the Omicron variant in one, and an undetermined in one. The undermined patient was identified as Delta using whole‐genome sequencing, but samples showed a mixed population of Delta and Omicron variants. This patient was analyzed for viral quasispecies by long‐read and Sanger sequencing using a full‐length spike gene amplicon. In addition to the Delta and Omicron sequences, the viral quasispecies analysis identified nine different genetic recombinant sequences with various breakpoints between Delta and Omicron sequences. The nine detected recombinant sequences in the spike gene showed over 99% identity with viruses that were detected during the Delta and Omicron cocirculation period from the United States and Europe.ConclusionsThis study demonstrates that patients coinfected with different SARS‐CoV‐2 variants can generate various viral recombinants and that various recombinant viruses may be produced during the cocirculation of different variants.